Navigation Links
Biodesign researchers to develop new reagent pipeline for molecular medicine
Date:10/24/2011

w anti-cancer therapeutics. LaBaer's lab has one of the largest collections of human kinases, curating more than 500 genes, and has used this library, called DNASU, to find novel pathways for cancer drug resistance.

"Kinases play such a central role in the how body regulates itself and they affect so many different human diseases that they were a logical place to start," said LaBaer. "But obviously, what excites us the most is that we can apply this approach to any protein that is important to human health. Our lab has a gene collection capable of producing 13,000 of the 20,000 proteins found in humans, so we have a lot of opportunity."

Their ambitious goal by the end of the funding period is to manufacture more than 4,000 new affinity reagents candidates to target against these 100 human kinases, opening up entirely new vistas for cancer research.

"Once this platform is developed, we hope to have demonstrated and validated the versatility of these new reagents and make them available to the greater scientific community and industrial collaborators to advance biomedical research," said Chaput. "We will have the ability to generate affinity reagents for any protein of interest."

SIDEBAR

The Missing LINC

At the heart of DNA synbody technology lays the ability to imagine entirely new uses for the twisting ladder of the DNA helix.

Chaput refers to DNA synbody assembly technology by a short acronym: ligand interactions by nucleotide conjugates (LINC). This patented technology uses DNA as a programmable scaffold dotted with pairs of peptides around the helix.

"We construct these molecules in a single-pot reaction," said Chaput. "Our DNA synbodies are unique reagents that use a short DNA backbone to support a pair of specific peptides at defined spacing and angular rotation."

Starting with a vast, peptide library of more than 1 trillion candidates for each protein target, Chaput q
'/>"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
480-727-0369
Arizona State University
Source:Eurekalert  

Page: 1 2 3 4

Related medicine news :

1. TGen, Tecan and ASU Biodesign Institute develop sample preparation solution for proteomic research
2. Biodesign hosts international consortium on screening for lung cancer
3. Researchers get $3 million National Institutes of Health grant for mathematical models of prostate cancer aggressiveness
4. Researchers find coupling of proteins promotes glioblastoma development
5. New instrument helps researchers see how diseases start and develop in minute detail
6. Teen Drivers Prone to G-Force Errors, Researchers Say
7. Autistic brains develop more slowly than healthy brains UCLA researchers say
8. Penn researchers demonstrate efficacy of non-Hodgkins lymphoma vaccine
9. Miriam Hospital researchers pilot new acute hepatitis C screening strategy for HIV-infected patients
10. Researchers discover why steroid treatment for COPD is ineffective
11. Researchers find possible link between bacterium and colon cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Biodesign researchers to develop new reagent pipeline for molecular medicine
(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
... cancers, especially leukemia, have improved greatly in the ... seem to face many health,and lifestyle challenges as ... and treatment methods, many continue to struggle with ... of life, according to a,study prepublished online in ...
... March 31 Hillenbrand,Industries, Inc. (NYSE: HB ) ... previously announced cash tender offer to purchase any,and all ... (CUSIP No.,431573AD6). The tender offer was made pursuant to ... to Purchase") and the related Letter of,Transmittal, which set ...
... 31 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... under which it may sell up to $50,million of ... a,24-month period. Alexza is not obligated to utilize any ... into and consummate other equity and,debt financing transactions., ...
... a Solid Foundation for Marriage and Family, ... offering an innovative program, "Supporting Healthy Marriage" to ... The purpose,of the program, administered by University Behavioral ... build a solid foundation,for marriage and family through ...
... to Consulting Addresses Fears That Lawyers Have That, ... Accurately Describes The Business, WASHINGTON, March 31 ... announced it is,becoming the first in the nation ... attorney. It had previously been the first in ...
... reduce lead dust during renovations , , MONDAY, March ... issued new rules designed to protect children from ... to homes and buildings. , Starting in ... standards" that are designed to reduce potential exposure ...
Cached Medicine News:Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 2Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 3Health News:Childhood Leukemia Survivors Struggle With Long-Term Comorbidities 4Health News:Hillenbrand Industries, Inc. Announces Expiration and Final Results of its Previously Announced 'Any and All' Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009 2Health News:Hillenbrand Industries, Inc. Announces Expiration and Final Results of its Previously Announced 'Any and All' Cash Tender Offer for its 4.50 Percent Senior Notes Due 2009 3Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 2Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 3Health News:Alexza Secures $50 Million Committed Equity Financing Facility With Azimuth Opportunity, Ltd. 4Health News:'Supporting Healthy Marriage' Program Offered by Montefiore 2Health News:Leventhal Weight Loss Incorporated Becomes First in the Nation Executive Weight Loss Consulting Service for Attorneys by an Attorney 2Health News:New Rule Seeks to Protect Kids From Lead Paint 2
(Date:12/17/2014)... Revenue and earnings above the previous ... development In the past 2013/14 fiscal year (ended ... to EUR 4.287 billion (last year: EUR 4.190 billion) despite ... EUR 360 million. "Overall, 2013/14 was a successful fiscal year ... President and CEO of Carl Zeiss AG. "Thanks to our ...
(Date:12/17/2014)... , Dec. 17, 2014  Beamz Interactive, Inc. ... music products, today announced that it has signed ... manufacturer and supplier of innovative prosthetic, orthotic and ... part of the agreement, RSL Steeper will promote ... specifically configured for use within UK residential care ...
(Date:12/17/2014)... 17, 2014  RXi Pharmaceuticals Corporation (NASDAQ: ... discovering, developing and commercializing innovative therapies addressing major ... of enrollment in its first Phase 2a study, ... confirmed the 1-month findings that were reported in ... - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
... 1 Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... obesity, today announced that the U.S. Food and Drug ... Drug Application (NDA) for Contrave® (naltrexone SR/bupropion SR), its ... is based on a substantial body of evidence gathered ...
... , IRVINE, Calif. , June 1 Cardiogenesis ... present at the Noble Financial Sixth Annual Equity Conference - ONTRACK ... Hollywood, Florida .  Executive Chairman Paul J. McCormick will ... at 5:00 pm Eastern Time ( 2:00 pm ...
Cached Medicine Technology:Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity 2Orexigen® Therapeutics Announces FDA Acceptance of Contrave® New Drug Application for the Treatment of Obesity 3Cardiogenesis Corporation to Present at Noble Financial - ONTRACK 2010 2
Straight heavy shafts with 7 mm tying surface. Wide serrated handle, polished finish. Overall length 4.2 inches....
Tying forceps with 6.5 mm tying platform. Round handle with flats provide flexibility of round handle with the stability of a flat handle. Straight shafts. Overall length 3.9 inches....
Curved shafts with 4 mm tying platform. Serrated handle with dull finish. Manufactured in titanium. Overall length 3.3 inches....
Straight 6 mm platform. McPherson handle. Manufactured in titanium. Overall length 3.3 inches....
Medicine Products: